Metabolic syndrome in childhood - causes and effects

Ram Weiss1

  • 1Hebrew University-Hadassah Braun School of Public Health and Community Medicine, Faculty of Medicine, Jerusalem, Israel.

Endocrine Development
|June 17, 2010
PubMed

Insights

Metabolic syndrome in obese children, driven by insulin resistance and abnormal fat deposition, predicts future cardiovascular risks. Early identification through risk factor clustering is crucial for managing long-term health outcomes.

Area of Science:

  • Pediatrics
  • Metabolic Disorders
  • Cardiovascular Health

Background:

  • Metabolic syndrome is a cluster of cardiovascular risk factors driven by insulin resistance.
  • In obese children, insulin resistance stems from visceral and tissue-specific fat deposition.
  • This leads to compensatory hyperinsulinemia, manifesting the syndrome's biochemical and clinical signs.

Purpose of the Study:

  • To explore the development and implications of metabolic syndrome in obese children.
  • To address the limitations in defining metabolic syndrome in pediatric populations.
  • To underscore the importance of risk stratification for metabolic syndrome in childhood.

Main Methods:

  • The study reviews the pathophysiology of metabolic syndrome in pediatric obesity.
  • It discusses the challenges in applying diagnostic criteria across different ethnicities and developmental stages.
  • It analyzes the association between childhood metabolic syndrome risk factors and adult atherogenesis.

Main Results:

  • Obesity in children leads to fat deposition in visceral and insulin-responsive tissues, causing insulin resistance.
  • Compensatory hyperinsulinemia maintains insulin sensitivity in some pathways, leading to syndrome manifestations.
  • Childhood clustering of metabolic syndrome risk factors correlates with accelerated adult atherogenesis.

Conclusions:

  • Despite definitional challenges in children, metabolic syndrome's risk factor cluster is linked to future cardiovascular disease.
  • Threshold-based definitions remain valuable for risk stratification and monitoring in pediatric populations.
  • Early identification and management are essential for mitigating long-term health consequences.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...